Cargando…

Risk factors of proteinuria and potentially protective effect of renin–angiotensin system inhibitors in patients with renal cell carcinoma receiving axitinib

PURPOSE: Patients receiving vascular endothelial growth factor–tyrosine kinase inhibitors are at a risk of developing proteinuria. Renin–angiotensin system (RAS) inhibitors exert renoprotective effects and might reduce proteinuria risk in these patients. We investigated the risk factors for and prot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ikesue, Hiroaki, Yamaoka, Kenta, Matsumoto, Ayako, Hirabatake, Masaki, Muroi, Nobuyuki, Yamasaki, Toshinari, Kawakita, Mutsushi, Hashida, Tohru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135790/ https://www.ncbi.nlm.nih.gov/pubmed/35254504 http://dx.doi.org/10.1007/s00280-022-04408-4

Ejemplares similares

Pharmacist-Urologist Collaborative Management Improves Clinical Outcomes in Patients With Castration-Resistant Prostate Cancer Receiving Enzalutamide
por: Hirabatake, Masaki, et al.
Publicado: (2022)

Safety and blood levels of daratumumab after switching from intravenous to subcutaneous administration in patients with multiple myeloma
por: Yamaoka, Kenta, et al.
Publicado: (2023)

Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases
por: Ikesue, Hiroaki, et al.
Publicado: (2021)

Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score–matched analysis
por: Ikesue, Hiroaki, et al.
Publicado: (2021)

Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases
por: Ikesue, Hiroaki, et al.
Publicado: (2021)

Pharmacokinetics of Temozolomide in a Patient With Glioblastoma Undergoing Hemodialysis: A Short Communication
por: Tanaka, Fumiaki, et al.
Publicado: (2023)

Population Pharmacokinetics of Nivolumab in Japanese Patients with Nonsmall Cell Lung Cancer
por: Tohi, Makiko, et al.
Publicado: (2023)

Evaluation of the usefulness of protocol‐based pharmacist‐facilitated laboratory monitoring to ensure the safety of immune checkpoint inhibitors in patients with lung cancer
por: Ikesue, Hiroaki, et al.
Publicado: (2020)

Evaluating the safety and efficiency of robotic dispensing systems
por: Takase, Tomoki, et al.
Publicado: (2022)

Safety and efficacy evaluation of low-dose trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis pneumonia in HIV uninfected patients undergoing hemodialysis: a retrospective observational study
por: Yamashita, Kanae, et al.
Publicado: (2021)

Effect of the number of dose adjustment factors on bleeding risk in patients receiving 30 mg/day edoxaban
por: Takase, Tomoki, et al.
Publicado: (2019)

Management of proteinuria: blockade of the renin–angiotensin–aldosterone system
por: Athavale, Akshay, et al.
Publicado: (2020)

Association between 25-hydroxyvitamin D levels and COVID-19 severity
por: Takase, Tomoki, et al.
Publicado: (2022)

Polypharmacy-associated potential contraindications of drug prescriptions in patients with primary angle closure disease in a real-world setting
por: Tanaka, Fumiaki, et al.
Publicado: (2021)

Population pharmacokinetics and exposure–clinical outcome relationship of remdesivir major metabolite GS‐441524 in patients with moderate and severe COVID‐19
por: Tamura, Ryo, et al.
Publicado: (2023)

Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID‐19
por: Irie, Kei, et al.
Publicado: (2020)

RENIN PROTEINURIA IN THE RAT : I. THE RELATION BETWEEN THE PROTEINURIA AND THE PRESSOR EFFECT OF RENIN
por: Addis, T., et al.
Publicado: (1949)

Effect of Renin-Angiotensin System Blockade on Mortality in Korean Hypertensive Patients with Proteinuria
por: Oh, Hyung Jung, et al.
Publicado: (2019)

Population pharmacokinetics of favipiravir in patients with COVID‐19
por: Irie, Kei, et al.
Publicado: (2021)

A simplified method for therapeutic drug monitoring of mitotane by gas chromatography‐electron ionization‐mass spectrometry
por: Ando, Motozumi, et al.
Publicado: (2020)

Effectiveness of Pharmacist–Physician Collaborative Management for Patients With Idiopathic Pulmonary Fibrosis Receiving Pirfenidone
por: Satsuma, Yukari, et al.
Publicado: (2020)

Everolimus pharmacokinetics and exposure-response relationship in Japanese patients with advanced breast cancer
por: Hirabatake, Masaki, et al.
Publicado: (2022)

Osteonecrosis of the Jaw Caused by Denosumab in Treatment-Naïve and Pre-Treatment with Zoledronic Acid Groups: A Time-to-Onset Study Using the Japanese Adverse Drug Event Report (JADER) Database
por: Hasegawa, Shiori, et al.
Publicado: (2022)

STUDIES ON THE MECHANISM OF EXPERIMENTAL PROTEINURIA INDUCED BY RENIN
por: Deodhar, Sharad D., et al.
Publicado: (1964)

Therapeutic potential of Ganoderma lucidum polysaccharide peptide in Doxorubicin-induced nephropathy: modulation of renin-angiotensin system and proteinuria
por: Fang, Hui, et al.
Publicado: (2023)

Renin-angiotensin system inhibitors may have an advantage over calcium channel blockers in reducing proteinuria in gastric cancer patients receiving ramucirumab
por: Chiba, Takeshi, et al.
Publicado: (2022)

MECHANISM OF PROTEINURIA : IV. EFFECT OF RENIN ON HEMOGLOBIN EXCRETION
por: Lippman, Richard W., et al.
Publicado: (1951)

Comprehensive Analysis of Adverse Events Induced by PARP Inhibitors Using JADER and Time to Onset
por: Yamaoka, Kenta, et al.
Publicado: (2022)

What’s new in the renin-angiotensin system?: What’s new in the renin-angiotensin system?
por: Smith, A. I., et al.
Publicado: (2004)

Chronotherapy with a Renin-angiotensin System Inhibitor Ameliorates Renal Damage by Suppressing Intrarenal Renin-angiotensin System Activation
por: Aoki, Taro, et al.
Publicado: (2020)

Correction to: Comparison between 5-aminolevulinic acid photodynamic diagnosis and narrow-band imaging for bladder cancer detection
por: Hagimoto, Hiroki, et al.
Publicado: (2022)

Comparison between 5-aminolevulinic acid photodynamic diagnosis and narrow-band imaging for bladder cancer detection
por: Hagimoto, Hiroki, et al.
Publicado: (2021)

Complete remission of renal cell carcinoma with lung carcinomatous lymphangiosis after primary therapy with immune checkpoint inhibitors followed by partial nephrectomy for surgical consolidation
por: Kambe, Takanari, et al.
Publicado: (2022)

The Renin-Angiotensin System Textbook
por: Cumming, Allan D
Publicado: (1994)

Brain renin angiotensin in disease
por: Phillips, M. Ian, et al.
Publicado: (2008)

The circulating renin-angiotensin-aldosterone system is down-regulated in dogs with glomerular diseases compared to other chronic kidney diseases with low-grade proteinuria
por: Grandt, Lisa-Maria, et al.
Publicado: (2022)

Interaction between warfarin and short-term intravenous amiodarone in intensive care unit patients after cardiac surgery
por: Takase, Tomoki, et al.
Publicado: (2018)

Involvement of local renin‐angiotensin system in immunosuppression of tumor microenvironment
por: Nakamura, Kenta, et al.
Publicado: (2017)

Impact of renal sinus protrusions on achieving trifecta in robot‐assisted partial nephrectomy
por: Hattori, Yuto, et al.
Publicado: (2023)

Do Genetic Variants of the Renin-Angiotensin System Predict Blood Pressure Response to Renin-Angiotensin System–Blocking Drugs? A Systematic Review of Pharmacogenomics in the Renin-Angiotensin System
por: Konoshita, Tadashi
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_tmu4fnad7qvinbu2hklennfisr